Public Health | October 29, 2021
Mandaviya launches the sixth edition of National Formulary of India (NFI)
The NFI is published to promote the rational use of medicines in the country.
The NFI is published to promote the rational use of medicines in the country.
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
It answers the most basic questions from a patient’s perspective
A total of 12 generic medicines have been included in the list
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Key takeaways of recent quarter & conference call highlights
Subscribe To Our Newsletter & Stay Updated
